Contact us on (02) 8445 2300
For all customer service and order enquiries

Woodslane Online Catalogues

9781615374977 Academic Inspection Copy

Psychedelics

Transforming Psychiatry
Description
Table of
Contents
Google
Preview

Few topics in psychiatry over the past few years have generated as much curiosity and excitement among clinicians and laypeople as the use of psychedelics. For mental health professionals, psychedelics offer an opportunity to expand existing treatment options and to explore new ones that have the potential to change neuroplasticity and neuroconnectivity. For patients, they offer the hope of relief from illnesses that have not responded adequately to traditional treatments.

When approaching the use of psychedelics in treatment, it is important to separate science from sensationalism. Expert-vetted and rigorously researched, Psychedelics: Transforming Psychiatry delivers an authoritative review of the current knowledge and evidence for the use of psychedelics in practice. Organized into three parts, this volume covers

* The history of psychedelic research and treatment, as well as the pharmacological and neurobiological mechanisms that underpin how these substances work
* Clinical applications for targeted illnesses that include mood disorders, PTSD, OCD and anxiety disorders, and substance use disorders
* Precautions and risks when using psychedelics, the role of psychotherapy when leveraging these substances, and potential future uses

The contributions from an international panel of recognized experts are enriched throughout the text by key clinical takeaways, data tables, and extensive references. This is a thoughtful and informative review of the current, rapidly developing landscape surrounding psychedelics in medicine.

Table of Contents Introduction Part I: Context, History, and Biological Underpinnings of Psychedelic Treatment Chapter 1. Psychedelic Research and Treatment: Brief History of a Key Pioneers Chapter 2. Pharmacological and Neurobiological Mechanisms of Action of Psychedelic substances Part II: Illness Targets for Psychedelic Research and Treatment Chapter 3. The Illness Targets: Mood Disorders and Suicide Chapter 4. MDMA-Assisted Therapy for Treatment of PTSD Chapter 5. Psychedelic Treatment of OCD and Anxiety Disorders: Early Work Chapter 6. Psychedelics in the Treatment of Substance Use Disorders Chapter 7. The Therapeutic Use of Psychedelics in the Treatment of Psycho-Existential Distress in Palliative and End-of-Life Care Chapter 8. Psychedelic Treatment for Emerging Indications: Eating Disorders, Autism, and Chronic Pain Management Part III: Considerations for Implementing Psychedelic Treatment Chapter 9. Psychedelics and Well-Being: Enhancements and Risks Chapter 10. The Psychedelic Therapy Treatment Process Chapter 11. The Future of Psychedelics in Psychiatry

Google Preview content